• INDUSTRY FORUM
• INDUSTRY TASK FORCE
• EGEE BUSINESS ASSOCIATES

• WHO USES EGEE
• USER SERVICES & TRAINING
• USER INFORMATION

• CONFERENCES
• USER FORUM EVENTS
• TRAINING EVENTS
• INDUSTRY DAYS
• RELATED GRID EVENTS

• RELATED PROJECTS
• MORE PROJECTS
• COLLABORATING WITH EGEE

• LATEST NEWS
• NEWSLETTERS
• INFORMATION SHEETS
• PRESS RELEASES
• PRESS OFFICE
• MULTIMEDIA
• NEWS FROM RELATED PROJECTS

EGEE GRID ATTACKS AVIAN FLU

During April, a collaboration of Asian and European laboratories has analysed 300,000 possible drug components against the avian flu virus H5N1 using the EGEE Grid infrastructure. Find out more about full analysis and of course the results so far...

During April, a collaboration of Asian and European laboratories has analysed 300,000 possible drug components against the avian flu virus H5N1 using the EGEE Grid infrastructure. The goal was to find potential compounds that can inhibit the activities of an enzyme on the surface of the influenza virus, the so-called neuraminidase, subtype N1. Using the Grid to identify the most promising leads for biological tests could speed up the development process for drugs against the influenza virus.

Find out more about full analysis and of course the results so far from the EGEE Press Release in here in English.

Also available in

Bulgarian
Czech
French
German
Greek
Italian
Polish
Portuguese
Russian
Serbian
Slovakian
Spanish